CN116617331A - Bagged seasoning tea for treating gout - Google Patents
Bagged seasoning tea for treating gout Download PDFInfo
- Publication number
- CN116617331A CN116617331A CN202310582267.5A CN202310582267A CN116617331A CN 116617331 A CN116617331 A CN 116617331A CN 202310582267 A CN202310582267 A CN 202310582267A CN 116617331 A CN116617331 A CN 116617331A
- Authority
- CN
- China
- Prior art keywords
- tea
- bagged
- prepared
- drying
- mixed powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000005569 Gout Diseases 0.000 title claims abstract description 36
- 235000011194 food seasoning agent Nutrition 0.000 title claims abstract description 13
- 241001122767 Theaceae Species 0.000 title abstract 4
- 244000269722 Thea sinensis Species 0.000 claims description 31
- 239000007788 liquid Substances 0.000 claims description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 235000013616 tea Nutrition 0.000 claims description 22
- 239000011812 mixed powder Substances 0.000 claims description 21
- 238000000855 fermentation Methods 0.000 claims description 20
- 230000004151 fermentation Effects 0.000 claims description 20
- 108090000790 Enzymes Proteins 0.000 claims description 18
- 102000004190 Enzymes Human genes 0.000 claims description 18
- 229940088598 enzyme Drugs 0.000 claims description 18
- 241000186018 Bifidobacterium adolescentis Species 0.000 claims description 16
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 16
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 16
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 16
- 239000002994 raw material Substances 0.000 claims description 16
- 238000001035 drying Methods 0.000 claims description 14
- 238000001914 filtration Methods 0.000 claims description 14
- 239000004365 Protease Substances 0.000 claims description 11
- 230000004913 activation Effects 0.000 claims description 10
- 108010059892 Cellulase Proteins 0.000 claims description 9
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 9
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 9
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 9
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 9
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 9
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 9
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 9
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 9
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 9
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 9
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 9
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 9
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 9
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 9
- 108090000270 Ficain Proteins 0.000 claims description 9
- 241000234435 Lilium Species 0.000 claims description 9
- 240000002853 Nelumbo nucifera Species 0.000 claims description 9
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 9
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 9
- 244000197580 Poria cocos Species 0.000 claims description 9
- 235000008599 Poria cocos Nutrition 0.000 claims description 9
- 235000006468 Thea sinensis Nutrition 0.000 claims description 9
- 235000020279 black tea Nutrition 0.000 claims description 9
- 229940106157 cellulase Drugs 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 9
- 235000019836 ficin Nutrition 0.000 claims description 9
- POTUGHMKJGOKRI-UHFFFAOYSA-N ficin Chemical compound FI=CI=N POTUGHMKJGOKRI-UHFFFAOYSA-N 0.000 claims description 9
- 230000001580 bacterial effect Effects 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 238000009835 boiling Methods 0.000 claims description 7
- 238000004140 cleaning Methods 0.000 claims description 7
- 238000012258 culturing Methods 0.000 claims description 7
- 238000004108 freeze drying Methods 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 239000008223 sterile water Substances 0.000 claims description 7
- 230000001954 sterilising effect Effects 0.000 claims description 7
- 238000005303 weighing Methods 0.000 claims description 7
- 239000001963 growth medium Substances 0.000 claims description 5
- 239000002054 inoculum Substances 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 4
- 239000004382 Amylase Substances 0.000 claims description 2
- 102000013142 Amylases Human genes 0.000 claims description 2
- 108010065511 Amylases Proteins 0.000 claims description 2
- 108090000145 Bacillolysin Proteins 0.000 claims description 2
- 102000035092 Neutral proteases Human genes 0.000 claims description 2
- 108091005507 Neutral proteases Proteins 0.000 claims description 2
- 108090000526 Papain Proteins 0.000 claims description 2
- 102000004142 Trypsin Human genes 0.000 claims description 2
- 108090000631 Trypsin Proteins 0.000 claims description 2
- 235000019418 amylase Nutrition 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims description 2
- 239000002609 medium Substances 0.000 claims description 2
- 229940055729 papain Drugs 0.000 claims description 2
- 235000019834 papain Nutrition 0.000 claims description 2
- -1 pectase Proteins 0.000 claims description 2
- 239000012588 trypsin Substances 0.000 claims description 2
- 240000000171 Crataegus monogyna Species 0.000 claims 3
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 abstract description 11
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 abstract description 9
- 229940116269 uric acid Drugs 0.000 abstract description 9
- 210000003734 kidney Anatomy 0.000 abstract description 8
- 210000004185 liver Anatomy 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 7
- 230000006378 damage Effects 0.000 abstract description 4
- 241000721047 Danaus plexippus Species 0.000 abstract description 3
- 238000003916 acid precipitation Methods 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 230000004060 metabolic process Effects 0.000 abstract description 3
- 210000000952 spleen Anatomy 0.000 abstract description 3
- 210000002784 stomach Anatomy 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 238000005728 strengthening Methods 0.000 abstract description 2
- 239000003814 drug Substances 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 7
- 241001092040 Crataegus Species 0.000 description 6
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 4
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 208000001647 Renal Insufficiency Diseases 0.000 description 4
- 208000037157 Azotemia Diseases 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 201000006370 kidney failure Diseases 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 208000009852 uremia Diseases 0.000 description 3
- 206010018634 Gouty Arthritis Diseases 0.000 description 2
- 201000001431 Hyperuricemia Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229960001338 colchicine Drugs 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 206010070840 Gastrointestinal tract irritation Diseases 0.000 description 1
- 208000000857 Hepatic Insufficiency Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023232 Joint swelling Diseases 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 206010046337 Urate nephropathy Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 description 1
- 229960003459 allopurinol Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000003818 metabolic dysfunction Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 229960002895 phenylbutazone Drugs 0.000 description 1
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000008085 renal dysfunction Effects 0.000 description 1
- 206010038464 renal hypertension Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/163—Liquid or semi-liquid tea extract preparations, e.g. gels, liquid extracts in solid capsules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/166—Addition of, or treatment with, enzymes or microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Food Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Dispersion Chemistry (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides bagged seasoning tea for treating gout, and belongs to the technical field of seasoning tea. The bagged seasoning tea disclosed by the invention is a medicinal and edible product, has a scientific formula, is mainly used for strengthening vital qi, nourishing kidney and liver, has excellent compatibility of monarch and minister materials, can block gout attack, has no toxic or side effect, can comprehensively correct uric acid metabolism, thoroughly eliminates uric acid precipitation, is not easy to relapse after treatment, is thorough in treatment and convenient to take, does not damage spleen and stomach, can well protect liver and kidney, and has a wide application prospect.
Description
Technical Field
The invention relates to the technical field of seasoning tea, in particular to bagged seasoning tea for treating gout.
Background
Gout is a disease that results in tissue damage due to long-term purine metabolic dysfunction, elevated blood uric acid. Clinical statistics show that gout can cause a plurality of serious complications such as coronary heart disease, uremia, renal failure, nausea, tumor and the like. The persistent hyperuricemia of gout patients can cause excessive urate crystals to precipitate in coronary arteries, and the coagulation of platelets and bad cholesterol can easily form atherosclerosis to cause coronary heart disease. In addition, prolonged hyperuricemia can cause excessive urate crystals to precipitate in the kidneys, resulting in gouty nephropathy, leading to kidney stones, uremia and renal failure. Half of gout patients develop renal hypertension due to renal dysfunction. Furthermore, accumulation of a large amount of toxins may cause canceration of the body. Gout has been a high risk factor for cancer onset in many countries in europe and america.
At present, western medicine has no radical cure method for pain and wind, and only symptomatic treatment is carried out. Colchicine is generally used clinically to relieve acute episodes of gout, or to relieve pain, pain-relieving and inflammation-diminishing phenylbutazone, and to relieve pain. Once the tophus is formed and large, it can only be removed by surgery. And the long-term excessive taking of western medicines such as colchicine and the like has great harm to the liver and the kidney. It is counted that nearly 1/4 of patients eventually develop uremia, renal failure, etc. In addition, the traditional western medicine treatment can not radically cure and repeatedly attack, and is also easy to cause gastrointestinal irritation, rash, drug heat and the like.
Disclosure of Invention
The invention aims to provide the bagged seasoning tea for treating gout, which is a medicinal and edible product, has a scientific formula, mainly strengthens healthy qi, nourishes kidney and liver, has excellent compatibility of monarch and minister materials, can block gout attack, has no toxic or side effect, can comprehensively correct uric acid metabolism, thoroughly eliminates uric acid precipitation, is not easy to relapse after treatment, is thorough in treatment and convenient to take, does not damage spleen and stomach, can well protect liver and kidney, and has wide application prospect.
The technical scheme of the invention is realized as follows:
the invention provides a bagged seasoning tea for treating gout, which comprises the following raw materials: black tea, hawthorn, poria cocos, chinese yam, dried orange peel, lotus leaf and lily.
As a further improvement of the invention, the invention is prepared from the following raw materials in weight g: 10-15g of black tea, 3-5g of hawthorn, 5-7g of poria cocos, 4-6g of Chinese yam, 2-3g of dried orange peel, 1-3g of lotus leaf and 3-5g of lily.
As a further improvement of the invention, the invention is prepared from the following raw materials in weight g: 12g of black tea, 4g of hawthorn, 6g of poria cocos, 5g of Chinese yam, 2.5g of dried orange peel, 2g of lotus leaf and 4g of lily.
The invention further provides a preparation method of the bagged seasoned tea for treating gout, which comprises the following steps:
s1, weighing the raw materials according to a proportion, cleaning, drying and crushing to obtain mixed powder;
s2, adding the mixed powder prepared in the step S1 into water, heating, boiling, extracting, filtering and drying to obtain an extract;
s3, respectively inoculating lactobacillus plantarum and bifidobacterium adolescentis into a Gao's medium, and performing activation culture to obtain strain seed liquid;
s4, adding the filter residues obtained in the step S2 into sterile water, sterilizing, inoculating lactobacillus plantarum and bifidobacterium adolescentis strain seed liquid and complex enzyme obtained in the step S3, fermenting and culturing, filtering, and freeze-drying to obtain a fermentation product;
s5, uniformly mixing the extract prepared in the step S2 and the fermentation product prepared in the step S4 to prepare the bagged seasoned tea for treating gout.
As a further improvement of the present invention, the solid-to-liquid ratio of the mixed powder and water in step S2 is 1:5-10g/mL, wherein the extraction time is 2-3h.
As a further improvement of the invention, the condition of the activation culture in the step S3 is 36-38 ℃,50-70r/min, the activation culture is carried out for 18-24 hours, and the bacterial seed liquid contains 10 percent of bacteria 8 -10 9 cfu/mL。
As a further improvement of the invention, the inoculation amount of the lactobacillus plantarum and bifidobacterium adolescentis strain seed liquid in the step S4 is 2-3% and 1-2% respectively, the compound enzyme is at least one of cellulase, pectase, papain, ficin, neutral protease, trypsin and amylase, the addition amount of the compound enzyme is 1-2wt% of the total mass of the system, the fermentation culture condition is 36-38 ℃,50-70r/min, and the fermentation culture is 36-48h.
As a further improvement of the invention, the complex enzyme comprises cellulase and ficin with a mass ratio of 5-7:2.
As a further improvement of the present invention, the mass ratio of the extract to the fermentation product in step S5 is 5-7:10-12.
As a further improvement of the present invention, the method specifically comprises the following steps:
s1, weighing the raw materials according to a proportion, cleaning, drying and crushing to obtain mixed powder;
s2, adding the mixed powder prepared in the step S1 into water, wherein the solid-liquid ratio of the mixed powder to the water is 1: extracting at 5-10g/mL under boiling for 2-3 hr, filtering, and drying to obtain extract;
s3, respectively inoculating lactobacillus plantarum and bifidobacterium adolescentis into a Gao's culture medium, and performing activation culture for 18-24 hours at 36-38 ℃ and 50-70r/min to obtain strain seed liquid with the bacterial content of 10 8 -10 9 cfu/mL；
S4, adding filter residues obtained in the step S2 into sterile water, sterilizing, inoculating lactobacillus plantarum and bifidobacterium adolescentis strain seed liquid obtained in the step S3, wherein the inoculum size is 2-3% and 1-2% of the total mass of the system, adding 1-2% of complex enzyme by weight, fermenting and culturing at 36-38 ℃ for 36-48 hours at 50-70r/min, filtering, and freeze-drying to obtain a fermentation product;
the compound enzyme comprises cellulase and ficin with the mass ratio of 5-7:2;
s5, uniformly mixing 5-7g of the extract prepared in the step S2 and 10-12 g of the fermentation product prepared in the step S4 to prepare the bagged seasoned tea for treating gout.
The invention has the following beneficial effects: the bagged seasoning tea disclosed by the invention is a medicinal and edible product, has a scientific formula, is mainly used for strengthening vital qi, nourishing kidney and liver, has excellent compatibility of monarch and minister materials, can block gout attack, has no toxic or side effect, can comprehensively correct uric acid metabolism, thoroughly eliminates uric acid precipitation, is not easy to relapse after treatment, is thorough in treatment and convenient to take, does not damage spleen and stomach, can well protect liver and kidney, and has a wide application prospect.
Detailed Description
The following description of the technical solutions in the embodiments of the present invention will be clear and complete, and it is obvious that the described embodiments are only some embodiments of the present invention, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
Example 1
The embodiment provides a bagged seasoned tea for treating gout.
Raw material composition (weight g): 10g of black tea, 3g of hawthorn, 5g of poria cocos, 4g of Chinese yam, 2g of dried orange peel, 1g of lotus leaf and 3g of lily.
The preparation method specifically comprises the following steps:
s1, weighing the raw materials according to a proportion, cleaning, drying and crushing to obtain mixed powder;
s2, adding the mixed powder prepared in the step S1 into water, wherein the solid-liquid ratio of the mixed powder to the water is 1: extracting with boiling water for 2 hr at 5g/mL, filtering, and drying to obtain extract;
s3, respectively inoculating lactobacillus plantarum and bifidobacterium adolescentis into a Gao's culture medium, and performing activation culture for 18 hours at 36 ℃ and 50 r/min to obtain strain seed liquid with the bacterial content of 10 8 cfu/mL；
S4, adding filter residues obtained in the step S2 into sterile water, sterilizing, inoculating lactobacillus plantarum and bifidobacterium adolescentis strain seed liquid obtained in the step S3, wherein the inoculum size is 2% and 1% respectively, then adding 1wt% of complex enzyme of the total mass of the system, fermenting and culturing at 36 ℃ for 36 hours at 50 r/min, filtering, and freeze-drying to obtain a fermentation product;
the compound enzyme comprises cellulase and ficin with a mass ratio of 5:2;
s5, uniformly mixing 5g of the extract prepared in the step S2 and 10g of the fermentation product prepared in the step S4, and preparing the bagged seasoned tea for treating gout.
Example 2
The embodiment provides a bagged seasoned tea for treating gout.
Raw material composition (weight g): 15g of black tea, 5g of hawthorn, 7g of poria cocos, 6g of Chinese yam, 3g of dried orange peel, 3g of lotus leaf and 5g of lily.
The preparation method specifically comprises the following steps:
s1, weighing the raw materials according to a proportion, cleaning, drying and crushing to obtain mixed powder;
s2, adding the mixed powder prepared in the step S1 into water, wherein the solid-liquid ratio of the mixed powder to the water is 1: heating and boiling 10g/mL for 3h, filtering, and drying to obtain extract;
s3, respectively inoculating lactobacillus plantarum and bifidobacterium adolescentis into a Gao's culture medium, and performing activation culture for 24 hours at 38 ℃ and 70r/min to obtain strain seed liquid with the bacterial content of 10 9 cfu/mL；
S4, adding filter residues obtained in the step S2 into sterile water, sterilizing, inoculating lactobacillus plantarum and bifidobacterium adolescentis strain seed liquid obtained in the step S3, wherein the inoculum size is 3% and 2% respectively, then adding 2wt% of complex enzyme of the total mass of the system, fermenting and culturing at 38 ℃ for 48 hours at 70r/min, filtering, and freeze-drying to obtain a fermentation product;
the compound enzyme comprises cellulase and ficin with the mass ratio of 7:2;
s5, uniformly mixing 7g of the extract prepared in the step S2 and 12g of the fermentation product prepared in the step S4 to prepare the bagged seasoned tea for treating gout.
Example 3
The embodiment provides a bagged seasoned tea for treating gout.
Raw material composition (weight g): 12g of black tea, 4g of hawthorn, 6g of poria cocos, 5g of Chinese yam, 2.5g of dried orange peel, 2g of lotus leaf and 4g of lily.
The preparation method specifically comprises the following steps:
s1, weighing the raw materials according to a proportion, cleaning, drying and crushing to obtain mixed powder;
s2, adding the mixed powder prepared in the step S1 into water, wherein the solid-liquid ratio of the mixed powder to the water is 1:7g/mL, heating and boiling for 2.5h, filtering, and drying to obtain extract;
s3, respectively inoculating lactobacillus plantarum and bifidobacterium adolescentis into a Gao's culture medium, and performing activation culture for 21 hours at 37 ℃ and 60 r/min to obtainTo strain seed liquid with a bacterial content of 10 9 cfu/mL；
S4, adding filter residues obtained in the step S2 into sterile water, sterilizing, inoculating lactobacillus plantarum and bifidobacterium adolescentis strain seed liquid obtained in the step S3, wherein the inoculum size is 2.5% and 1.5% respectively, then adding 1.5% by weight of complex enzyme of the total mass of the system, fermenting and culturing at 37 ℃ for 42h at 60 r/min, filtering, and freeze-drying to obtain a fermentation product;
the compound enzyme comprises cellulase and ficin with the mass ratio of 6:2;
s5, uniformly mixing 6g of the extract prepared in the step S2 and 11 g of the fermentation product prepared in the step S4, and preparing the bagged seasoned tea for treating gout.
Test example 1
120 cases of gouty arthritis patients. The random groups were four. Examples 1-3, 30 for each group, 30 for the control group.
Inclusion criteria:
(1) Meets the diagnosis standard in the diagnosis and treatment guide of primary gout formulated by the college of rheumatology of China medical society in 2011, meets the diagnosis standard of phlegm-dampness collateral obstruction type gout formulated by the Chinese medicine science of Zhou Zhong Ji, and the blood uric acid is more than or equal to 420 mu mo L/L after diet control;
(2) Age 22-65 years old;
(3) Voluntary test and sign informed consent.
Exclusion criteria:
(1) Combining severe cardiovascular and cerebrovascular diseases, liver and kidney insufficiency, severe gastrointestinal diseases and blood system diseases;
(2) Those who have affected uric acid by recent administration;
(3) Pregnant and lactating women;
(4) Serious joint deformity;
(5) Poor dietary control and therapeutic compliance.
In this study, the two groups were compared in terms of age, sex, body mass index, course of disease, etc., and the differences were not statistically significant (P > 0.05), and were comparable.
Basic treatment of treatment method: proper rest, avoiding tiredness and catching cold, avoiding high purine diet (such as seafood, animal viscera, bean products, etc.), prohibiting smoking and drinking, and drinking white boiled water of more than 2000mL each day. Control group: allopurinol tablet is orally taken half an hour after meals, 3 times/day, 100 mg/time (Shang Xin Yi Wan Xiang Chemie Co., ltd.). Examples 1-3 groups: a bag of seasoning tea for treating gout is prepared by soaking 3 times per day and 20g per time.
And (3) observing the indexes:
the Chinese medicine syndromes are integrated: the integration of the Chinese medicine symptoms of the two groups of patients is calculated respectively before treatment, 6 weeks after treatment and 12 weeks after treatment, and the evaluation standard of the 2002 edition of Chinese medicine clinical study guidelines is referred to, wherein the evaluation of the symptoms of joint pain, joint swelling, listlessness, aversion to cold, cold limbs, head and body heaviness, epigastric fullness and tophus 7 is carried out, and the symptoms of no symptom, mild symptom, moderate symptom and severe symptom are respectively 0, 2, 4 and 6 minutes, and then average division is calculated.
And (3) judging curative effect: clinical efficacy assessment is performed 12 weeks after treatment by referring to 2002 edition of "guidelines for clinical research on New Chinese medicine". The effect is shown: UA is reduced to less than or equal to 380 mu mo L/L after treatment, and is reduced by more than or equal to 30% compared with the UA before treatment; the method is effective: UA drops to less than or equal to 440 mu mo L/L after treatment, but more than 380 mu mo L/L, or drops by more than or equal to 15% but less than 30% compared with the prior treatment; invalidation: UA > 440 mu mo L/L after treatment, or decrease < 15% or even increase compared to pre-treatment. Total effective rate= (effective + effective) number of cases/total number of cases x 100%.
The results are shown in tables 1 and 2.
TABLE 1
| Group of | 0 week | For 6 weeks | For 12 weeks |
| Example 1 | 3.11±1.02 | 2.10±1.22 | 0.87±0.78 |
| Example 2 | 3.09±1.11 | 2.08±1.17 | 0.84±0.82 |
| Example 3 | 3.02±1.08 | 2.04±0.98 | 0.82±0.85 |
| Control group | 3.20±0.98 | 2.32±1.28 | 1.72±1.14 |
TABLE 2
| Group of | Has obvious effect | Effective and effective | Invalidation of |
| Example 1 | 12 | 17 | 1 |
| Example 2 | 13 | 16 | 1 |
| Example 3 | 14 | 16 | 0 |
| Control group | 6 | 18 | 6 |
From the above table, the bagged seasoning tea for treating gout prepared in the embodiments 1-3 has good effect of treating gouty arthritis.
The foregoing description of the preferred embodiments of the invention is not intended to be limiting, but rather is intended to cover all modifications, equivalents, alternatives, and improvements that fall within the spirit and scope of the invention.
Claims (10)
1. The bagged seasoning tea for treating gout is characterized by comprising the following raw materials: black tea, hawthorn, poria cocos, chinese yam, dried orange peel, lotus leaf and lily.
2. The bagged seasoned tea for treating gout according to claim 1, which is characterized by being prepared from the following raw materials in parts by weight: 10-15g of black tea, 3-5g of hawthorn, 5-7g of poria cocos, 4-6g of Chinese yam, 2-3g of dried orange peel, 1-3g of lotus leaf and 3-5g of lily.
3. The bagged seasoned tea for treating gout according to claim 1, which is characterized by being prepared from the following raw materials in parts by weight: 12g of black tea, 4g of hawthorn, 6g of poria cocos, 5g of Chinese yam, 2.5g of dried orange peel, 2g of lotus leaf and 4g of lily.
4. A method of preparing a teabag for the treatment of gout according to any of claims 1 to 3 comprising the steps of:
s1, weighing the raw materials according to a proportion, cleaning, drying and crushing to obtain mixed powder;
s2, adding the mixed powder prepared in the step S1 into water, heating, boiling, extracting, filtering and drying to obtain an extract;
s3, respectively inoculating lactobacillus plantarum and bifidobacterium adolescentis into a Gao's medium, and performing activation culture to obtain strain seed liquid;
s4, adding the filter residues obtained in the step S2 into sterile water, sterilizing, inoculating lactobacillus plantarum and bifidobacterium adolescentis strain seed liquid and complex enzyme obtained in the step S3, fermenting and culturing, filtering, and freeze-drying to obtain a fermentation product;
s5, uniformly mixing the extract prepared in the step S2 and the fermentation product prepared in the step S4 to prepare the bagged seasoned tea for treating gout.
5. The method according to claim 4, wherein the solid-to-liquid ratio of the mixed powder and water in step S2 is 1:5-10g/mL, wherein the extraction time is 2-3h.
6. The method according to claim 4, wherein the condition of the activation culture in the step S3 is 36-38deg.C, 50-70r/min, and the culture is activated for 18-24 hours, and the bacterial seed solution has a bacterial content of 10 8 -10 9 cfu/mL。
7. The preparation method of claim 4, wherein the seed solution of Lactobacillus plantarum and Bifidobacterium adolescentis in the step S4 is inoculated in an amount of 2-3% and 1-2% respectively, the compound enzyme is at least one of cellulase, pectase, papain, ficin, neutral protease, trypsin and amylase, the adding amount of the compound enzyme is 1-2wt% of the total mass of the system, the condition of fermentation culture is 36-38 ℃,50-70r/min, and the fermentation culture is 36-48h.
8. The preparation method according to claim 7, wherein the complex enzyme comprises cellulase and ficin in a mass ratio of 5-7:2.
9. The process according to claim 4, wherein the mass ratio of the extract to the fermentation product in step S5 is 5-7:10-12.
10. The preparation method according to claim 4, comprising the following steps:
s1, weighing the raw materials according to a proportion, cleaning, drying and crushing to obtain mixed powder;
s2, adding the mixed powder prepared in the step S1 into water, wherein the solid-liquid ratio of the mixed powder to the water is 1: extracting at 5-10g/mL under boiling for 2-3 hr, filtering, and drying to obtain extract;
s3, respectively inoculating lactobacillus plantarum and bifidobacterium adolescentis into a Gao's culture medium, and performing activation culture for 18-24 hours at 36-38 ℃ and 50-70r/min to obtain strain seed liquid with the bacterial content of 10 8 -10 9 cfu/mL；
S4, adding filter residues obtained in the step S2 into sterile water, sterilizing, inoculating lactobacillus plantarum and bifidobacterium adolescentis strain seed liquid obtained in the step S3, wherein the inoculum size is 2-3% and 1-2% respectively, then adding 1-2% of complex enzyme by weight of the total mass of the system, fermenting and culturing at 36-38 ℃ for 36-48h at 50-70r/min, filtering, and freeze-drying to obtain a fermentation product;
the compound enzyme comprises cellulase and ficin with the mass ratio of 5-7:2;
s5, uniformly mixing 5-7g of the extract prepared in the step S2 and 10-12 g of the fermentation product prepared in the step S4 to prepare the bagged seasoned tea for treating gout.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310582267.5A CN116617331A (en) | 2023-05-23 | 2023-05-23 | Bagged seasoning tea for treating gout |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310582267.5A CN116617331A (en) | 2023-05-23 | 2023-05-23 | Bagged seasoning tea for treating gout |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116617331A true CN116617331A (en) | 2023-08-22 |
Family
ID=87635960
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310582267.5A Pending CN116617331A (en) | 2023-05-23 | 2023-05-23 | Bagged seasoning tea for treating gout |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116617331A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110692978A (en) * | 2019-11-15 | 2020-01-17 | 湖南一线情农业有限公司 | Lily and Chinese yam cake capable of tonifying spleen and promoting appetite and preparation method of lily and Chinese yam cake |
| CN115500506A (en) * | 2022-10-08 | 2022-12-23 | 武汉新华扬生物股份有限公司 | Enzyme capable of relieving gout and reducing blood sugar and preparation method thereof |
-
2023
- 2023-05-23 CN CN202310582267.5A patent/CN116617331A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110692978A (en) * | 2019-11-15 | 2020-01-17 | 湖南一线情农业有限公司 | Lily and Chinese yam cake capable of tonifying spleen and promoting appetite and preparation method of lily and Chinese yam cake |
| CN115500506A (en) * | 2022-10-08 | 2022-12-23 | 武汉新华扬生物股份有限公司 | Enzyme capable of relieving gout and reducing blood sugar and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 中华中医药学会风湿病分会: "痛风和高尿酸血症病证结合诊疗指南", 《中医杂志》, vol. 62, no. 14, 31 July 2021 (2021-07-31), pages 1276 - 1288 * |
| 王新等: "中医药治疗高尿酸血症用药规律总结", 《辽宁中医药大学学报》, vol. 17, no. 8, 31 August 2015 (2015-08-31), pages 142 - 145 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106266229B (en) | Enzyme with blood replenishing effect and preparation method thereof | |
| CN112999261A (en) | Natto fermented composition capable of relieving arteriosclerosis and preparation method and application thereof | |
| CN114045233B (en) | Direct-vat fermentation microbial inoculum for relieving constipation type irritable bowel syndrome and preparation method and application thereof | |
| CN109439504A (en) | A kind of probiotics compound health vinegar and preparation method thereof | |
| CN106085788B (en) | Ginseng and medlar vinegar and preparation method and application thereof | |
| CN110859871A (en) | Composition for treating prostatitis and preparation method thereof | |
| CN106987504A (en) | A kind of production method of yellow rice wine | |
| CN114041593A (en) | Uric acid-reducing composite oligosaccharide enzyme and preparation method thereof | |
| CN106119065B (en) | Hericium erinaceus and red date vinegar and preparation method and application thereof | |
| CN116617331A (en) | Bagged seasoning tea for treating gout | |
| WO2018171672A1 (en) | Anti-cancer pharmaceutical composition and use thereof | |
| CN113876915B (en) | Uric acid reducing oral preparation and preparation method thereof | |
| CN105211436A (en) | The formula of a kind of loguat leaf health protection tea and manufacture craft thereof | |
| CN112294892B (en) | Fermented four-ingredient soup beverage composition with function of relieving dysmenorrhea and preparation method thereof | |
| CN104509748A (en) | Chicken feed additive and preparation method thereof | |
| CN109432349B (en) | Fungus symbiotic fermentation anti-tumor turmeric and preparation method thereof | |
| CN107898920A (en) | A kind of mouth containing product and preparation method for diabetes | |
| CN102166029A (en) | Functional drink of multi-bacterium health-keeping extract of mesona chinensis benth | |
| CN113197268A (en) | Sobering and liver-protecting soft drink and preparation method thereof | |
| CN106260359A (en) | A kind of Saussurea involucrata culture compositions Ganoderma tea and preparation method thereof | |
| CN111150065A (en) | Application of sea-buckthorn water-soluble extract in preparation for inhibiting Tau protein phosphorylation | |
| CN110272933A (en) | It is a kind of for alleviating the protein peptides and preparation method of dysmenorrhea and female menstrual period discomfort | |
| CN111729056A (en) | Anticancer medicine composition and its prepn | |
| CN104705743A (en) | Black lycium barbarum composite drink for warming uterus and losing weight for female and preparation method of black lycium barbarum composite drink | |
| CN116942742B (en) | Uric acid reducing traditional Chinese medicine composition and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |